CherylWillmanMD
Pathology • Albuquerque, NMAnatomic Pathology, Clinical Pathology
Professor, Pathology, University of New Mexico School of Medicine
Are you Dr. Willman?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 28 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
2325 Camino de Salud NE
UNM Cancer Research Treatment Center
Albuquerque, NM 87131Phone+1 505-272-5622
Summary
- Dr. Cheryl Willman, MD is a board certified pathologist in Albuquerque, New Mexico. She is currently licensed to practice medicine in New Mexico. She is affiliated with University of New Mexico Hospitals and is a Professor at University of New Mexico School of Medicine.
Education & Training
University of New Mexico School of MedicineResidency, Pathology-Anatomic and Clinical, 1981 - 1984
Mayo Clinic College of Medicine and Science (Rochester)Residency, Pathology-Anatomic and Clinical, 1981 - 1981- Mayo Clinic College of MedicineClass of 1981
Certifications & Licensure
NM State Medical License 1985 - 2025- American Board of Pathology Anatomic Pathology
Clinical Trials
- S0301 Cyclosporine, Daunorubicin, and Cytarabine in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia Start of enrollment: 2004 Jul 01
- S0535, Gemtuzumab and Combination Chemotherapy in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia Start of enrollment: 2007 Nov 15
- S9031-S9126-S9333-S9500-A, Studying Bone Marrow and Blood Samples From Patients With Acute Myeloid Leukemia Start of enrollment: 2008 Nov 01
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsGenomic Determinants of Outcome in Acute Lymphoblastic Leukemia.Ti-Cheng Chang, Wenan Chen, Chunxu Qu, Zhongshan Cheng, Dale Hedges
Journal of Clinical Oncology. 2024-10-10 - Exome Sequencing Identifies Carriers of the Autosomal Dominant Cancer Predisposition Disorders Beyond Current Practice Guideline Recommendations.N Jewel Samadder, Emily Gay, Vanda Lindpere, Michelle L Bublitz, Lorelei A Bandel
JCO Precision Oncology. 2024-07-01 - 2 citationsExamining the impact of age on the prognostic value of ELN-2017 and ELN-2022 acute myeloid leukemia risk stratifications: a report from the SWOG Cancer Research Network.Christina M Termini, Anna Moseley, Megan Othus, Frederick R Appelbaum, Thomas R Chauncey
Haematologica. 2023-11-01
Press Mentions
Mayo Clinic to Expand Access to State-of-the-Art Cancer Care Through Transformational GiftSeptember 10th, 2024- Exact Sciences to Provide Mayo Clinic Patients with Individualized Cancer Tumor Information to Inform TreatmentApril 4th, 2024
- FDA’s Fashoyin-Aje: Draft Guidance on Accelerated Approval Urges Reliance on Randomized Controlled TrialsMarch 31st, 2023
- Join now to see all
